← FDA Drug Approvals (Drugs@FDA)

THRIVE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAXOSMITHKLINE CONS · Approved 2007-06-19

Drug application

FDA Application #

ANDA077658

Application type

Abbreviated New Drug Application (Generic)

Brand name

THRIVE

Generic name

Nicotine Polacrilex

Active ingredients

NICOTINE POLACRILEX

Dosage form

GUM, CHEWING

Route

BUCCAL

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE CONS

First approval

2007-06-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown